5-Amino-1MQ Caps (50mg)
5-Amino-1MQ is a small-molecule compound studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cellular energy metabolism and fat-cell regulation. This capsule format delivers 5-Amino-1MQ in a stabilized oral dosage form for laboratory research use.
Researchers study 5-Amino-1MQ primarily for its role in adipocyte metabolism, NAD+ availability, and metabolic signaling pathways associated with fat-cell regulation.
GENIQ supplies 5-Amino-1MQ Caps strictly for laboratory research only—not for human or animal use.
$249.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is 5-Amino-1MQ Caps?
5-Amino-1MQ is a small-molecule compound studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cellular energy metabolism and fat-cell regulation. This capsule format delivers 5-Amino-1MQ in a stabilized oral dosage form for laboratory research use. Researchers study 5-Amino-1MQ primarily for its role in adipocyte metabolism, NAD+ availability, and metabolic signaling pathways associated with fat-cell regulation. GENIQ supplies 5-Amino-1MQ Caps strictly for laboratory research only—not for human or animal use.
Peptide Overview
5-Amino-1MQ is frequently studied in research focused on metabolic regulation, adipocyte biology, and cellular energy pathways. In controlled laboratory environments, researchers examine how 5-Amino-1MQ Caps may promote changes in:
| NNMT enzymatic activity in adipose tissue models |
| Cellular NAD+ and SAM metabolism |
| Adipocyte lipid accumulation markers |
| Metabolic rate signaling pathways |
| Fat-cell differentiation research models |
| Energy expenditure-related gene expression |
| Weight-regulation research protocols |
All findings remain limited to preclinical and in-vitro experimental environments.
History of 5-Amino-1MQ
5-Amino-1MQ was developed during research into NNMT inhibition as a strategy to influence adipocyte metabolism and cellular energy balance. Scientists identified that inhibiting NNMT alters methylation and NAD+ pathways associated with fat storage and metabolic rate. Because of this interaction, 5-Amino-1MQ became a compound of interest in studies involving:
| NNMT enzyme inhibition mechanisms |
| Adipose tissue metabolic models |
| Obesity and metabolic syndrome research |
| Cellular NAD+/SAM pathway studies |
| Aging and cellular senescence metabolism |
| Small-molecule oral bioavailability research |
Peptide Structure
Chemical Name: 5-amino-1-methylquinolinium iodide (5-Amino-1MQ) Classification: Small-molecule NNMT inhibitor Form Supplied: Oral capsule, 50mg per capsule (60 capsules per bottle)
Certificates of Analysis
Every batch of GENIQ 5-Amino-1MQ Caps is verified by third-party laboratory testing confirming identity, purity, and capsule content accuracy. Certificates of Analysis (COA) are available upon request for research verification.
Research Findings
Research involving 5-Amino-1MQ commonly focuses on:
| NNMT inhibition: Studies evaluate how blocking NNMT activity affects methylation and cellular energy pathways. |
| Adipocyte size regulation: Researchers investigate changes in fat-cell size and lipid storage in laboratory models. |
| Metabolic rate markers: Laboratory models track biochemical changes related to energy expenditure. |
| NAD+ availability: Experimental studies analyze cellular NAD+ levels following NNMT inhibition. |
| Oral bioavailability: Research examines absorption and stability of capsule-delivered small molecules. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
FAQ
What type of research is 5-Amino-1MQ Caps used for?
5-Amino-1MQ Caps is commonly used in studies involving NNMT inhibition, adipocyte metabolism, and metabolic-rate research.
Does GENIQ provide a Certificate of Analysis?
Yes. Every GENIQ compound includes a COA verifying identity and purity.
Is 5-Amino-1MQ approved for human or veterinary use?
No. 5-Amino-1MQ is not FDA-approved and is intended strictly for laboratory research, not for human or animal administration.
Does GENIQ provide dosing or preparation instructions?
No. GENIQ does not provide dosing, administration, or preparation instructions, as our compounds are supplied strictly for laboratory research.
Who should handle this compound?
5-Amino-1MQ Caps should only be handled by qualified researchers and laboratory professionals trained in proper handling procedures.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
5-Amino-1MQ is a small-molecule compound studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cellular energy metabolism and fat-cell regulation. This capsule format delivers 5-Amino-1MQ in a stabilized oral dosage form for laboratory research use.
Researchers study 5-Amino-1MQ primarily for its role in adipocyte metabolism, NAD+ availability, and metabolic signaling pathways associated with fat-cell regulation.
GENIQ supplies 5-Amino-1MQ Caps strictly for laboratory research only—not for human or animal use.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.